1 |
Zhang P, Lu X, Li Q, Lin X, Liu H, Ma X. 2012. Cloning and characterization of a thermostable urate oxidase from Microbacterium sp. strain ZZJ4-1. Sheng Wu Gong Cheng Xue Bao 28: 813-822.
|
2 |
Richette P, Bardin T. 2010. Gout. Lancet 375: 318-328.
DOI
ScienceOn
|
3 |
Saeed HM, Abdel-Fattah YR, Gohar YM, Elbaz MA. 2004. Purification and characterization of extracellular Pseudomonas aeruginosa urate oxidase enzyme. Pol. J. Microbiol. 53: 45-52.
|
4 |
Schiavon O, Caliceti P, Ferruti P, Veronese FM. 2000. Therapeutic proteins: a comparison of chemical and biological properties of uricase conjugated to linear or branched poly (ethylene glycol) and poly (N-acryloyl morpholine). Farmaco 55: 264-269.
DOI
ScienceOn
|
5 |
Shin HY, Kang HJ, Park ES, Choi HS, Ahn HS, Kim SY, et al. 2006. Recombinant urate oxidase (rasburicase) for the treatment of hyperuricemia in pediatric patients with hematologic malignancies: results of a compassionate prospective multicenter study in Korea. Pediatr. Blood Cancer 46: 439-445.
DOI
ScienceOn
|
6 |
SitiHatijah PM, Wan Ruhayu WR. 2013. Preliminary study on factors that enhanced the production of uricase by Aspergillus flavus. Int. J. Biosci. Biochem. Bioinform. 3: 513-515.
|
7 |
Vogt B. 2005. Urate oxidase (rasburicase) for treatment of severe tophaceous gout. Nephrol. Dial. Transplant. 20: 431-433.
DOI
ScienceOn
|
8 |
Woods DE, Schaffer MS, Rabin HR, Campbell GD, Sokol PA. 1986. Phenotypic comparison of Pseudomonas aeruginosa strains isolated from a variety of clinical sites. J. Clin. Microbiol. 24: 260-264.
|
9 |
Wretlind B, Pavlovskis OR. 1983. Pseudomonas aeruginosa elastase and its role in Pseudomonas infections. Rev. Infect. Dis. 5: S998-S1004.
DOI
|
10 |
Zhang J, Ren J, Li B, Liu S, Hou L, Fu L, et al. 2010. Construction, expression, purification and characterization of mutant of Aspergillus flavus urate oxidase. Sheng Wu Gong Cheng Xue Bao 26: 1102-1107.
|
11 |
Li J, Chen Z, Hou L, Fan H, Weng S, Xu C, et al. 2006. High-level expression, purification, and characterization of non-tagged Aspergillus flavus urate oxidase in Escherichia coli. Protein Expr. Purif. 49: 55-59.
DOI
ScienceOn
|
12 |
Jagger KS, Bahner DR, Warren RL. 1983. Protease phenotypes of Pseudomonas aeruginosa isolated from patients with cystic fibrosis. J. Clin. Microbiol. 17: 55-59.
|
13 |
Laemmli UK. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685.
DOI
ScienceOn
|
14 |
Lehejckova R, Demnerova K, Kralova B. 1986. Screening of microorganisms with uricase activity. Biotechnol. Lett. 8: 341-342.
DOI
|
15 |
Lyczak JB, Cannon CL, Pier GB. 2000. Establishment of Pseudomonas aeruginosa infection: lessons from a versatile opportunist. Microbes Infect. 2: 1051-1060.
DOI
ScienceOn
|
16 |
Nishiya Y, Hibi T, Oda J. 2002. A purification method of the diagnostic enzyme Bacillus uricase using magnetic beads and non-specific protease. Protein Expr. Purif. 25: 426-429.
DOI
ScienceOn
|
17 |
Oda M, Satta Y, Takenaka O, Takahata N. 2002. Loss of urate oxidase activity in hominoids and its evolutionary implications. Mol. Biol. Evol. 19: 640-653.
DOI
ScienceOn
|
18 |
Pfrimer P, de Moraes LM, Galdino AS, Salles LP, Reis VC, De Marco JL, et al. 2010. Cloning, purification, and partial characterization of Bacillus subtilis urate oxidase expressed in Escherichia coli. J. Biomed. Biotechnol. 2010: 674908.
DOI
|
19 |
Pui CH, Mahmoud HH, Wiley JM, Woods GM, Leverger G, Camitta B, et al. 2001. Recombinant urate oxidase for the prophylaxis or treatment of hyperuricemia in patients with leukemia or lymphoma. J. Clin. Oncol. 19: 697-704.
DOI
|
20 |
Colloc’h N, el Hajji M, Bachet B, L’Hermite G, Schiltz M, Prange T, et al. 1997. Crystal structure of the protein drug urate oxidase-inhibitor complex at 2.05 A resolution. Nat. Struct. Biol. 4: 947-952.
DOI
ScienceOn
|
21 |
Elmer K, Washington W, Jr Stephen A, William J, Gary P, Paul S, Gail W. 2006. Koneman's Color Atlas and Textbook of Diagnostic Microbiology, 6th Ed. Lippincott Williams and Wilkins, London.
|
22 |
Essam AA, Ali M, Fareed M. 2005. Studies on uricase induction in certain bacteria. Egyptian J. Biol. 7: 44-54.
|
23 |
Fazel R, Zarei N, Ghaemi N, Namvaran MM, Enayati S, Mirabzadeh Ardakani E, et al. 2014. Cloning and expression of Aspergillus flavus urate oxidase in Pichia pastoris. Springerplus 3: 395.
DOI
ScienceOn
|
24 |
Feig DI, Kang DH, Johnson RJ. 2008. Uric acid and cardiovascular risk. N. Engl. J. Med. 359: 1811-1821.
DOI
ScienceOn
|
25 |
George RL, Jr Sundy JS. 2012. Pegloticase for treating refractory chronic gout. Drugs Today (Barc). 48: 441-449.
|
26 |
Hogardt M, Heesemann J. 2010. Adaptation of Pseudomonas aeruginosa during persistence in the cystic fibrosis lung. Int. J. Med. Microbiol. 300: 557-562.
DOI
ScienceOn
|
27 |
Hummel M, Buchheidt D, Reiter S, Bergmann J, Adam K, Hehlmann R. 2005. Recurrent chemotherapy-induced tumor lysis syndrome (TLS) with renal failure in a patient with chronic lymphocytic leukemia - successful treatment and prevention of TLS with low-dose rasburicase. Eur. J. Haematol. 75: 518-521.
DOI
ScienceOn
|
28 |
Ishikawa J, Yamashita A, Mikami Y, Hoshino Y, Kurita H, Hotta K, et al. 2004. The complete genomic sequence of Nocardia farcinica IFM 10152. Proc. Natl. Acad. Sci. USA 101: 14925-14930.
DOI
ScienceOn
|
29 |
Ali UF, Ibrahim ZM. 2013. Effect of irradiation on uricase produced by two strains of Asperigillus niger. Life Sci. J. 10: 962-967.
|
30 |
Adamek V, Kralova B, Suchova M, Valentova O, Demnerova K. 1989. Purific ation of mic robial uric ase. J. Chromatogr. 497: 268-275.
DOI
ScienceOn
|
31 |
Anderson A, Vijayakumar S. 2012. Isolation and optimization of Pseudomonas aeruginosa for uricase production. Int. J. Pharma Biol. Sci. 3: 143-150.
|
32 |
Bradford MM. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248-254.
DOI
ScienceOn
|
33 |
Cammalleri L, Malaguarnera M. 2007. Rasburicase represents a new tool for hyperuricemia in tumor lysis syndrome and in gout. Int. J. Med. Sci. 4: 83-93.
DOI
|
34 |
Chen M, Cai L, Fang Z, Tian H, Gao X, Yao W. 2008. Sitespecific incorporation of unnatural amino acids into urate oxidase in Escherichia coli. Protein Sci. 17: 1827-1833.
DOI
ScienceOn
|
35 |
Chen Z, Wang Z, He X, Guo X, Li W, Zhang B. 2008. Uricase production by a recombinant Hansenula polymorpha strain harboring Candida utilis uricase gene. Appl. Microbiol. Biotechnol. 79: 545-554.
DOI
|
36 |
Chohan S, Becker MA. 2009. Update on emerging uratelowering therapies. Curr. Opin. Rheumatol. 21: 143-149.
DOI
ScienceOn
|